Document is current
Any future updates will be listed below
-
Authors
Fan, Huiqun
Zhan, Yang
Cheng, Xiaoying
Tan, Mintao
Li, Yingmeng
Xiong, Yanxia
Li, Qiong
Liu, Wenjun
-
Funding
Funding for this research was provided by:
Nanchang City High-level Scientific and Technological Innovation Talents “Double Hundred Plan” (Grant No. [2022]321)
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 24 February 2025
First Online: 9 March 2025
Declarations
:
: The authors declare no competing interests.
: All animal experiments in this study were approved by the experimental animal ethics committee of Jiangzhong Pharmaceutical Co., Ltd. (No. 20220415). All procedures were carried out according to Guidelines for the Care and Use of Laboratory Animals and the Chinese Legislation on Laboratory Animals. The reporting in this study follows the recommendations in the ARRIVE guidelines.
